LUP Statistics
Record
- Title
- Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.
- Type
- Journal Article
- Publ. year
- 2004
- Author/s
- Andersen, O; Elovaara, I; Färkkilä, M; Hansen, H J et al.
- Department/s
- Neurology, Lund
- In LUP since
- 2016-04-01
Downloads
Total | This Year | This Month |
475 | 15 | 1 |
United States of America | 213 (45%) |
Germany | 96 (20%) |
Hong Kong (China) | 43 (9%) |
China | 34 (7%) |
Ukraine | 14 (3%) |
Sweden | 10 (2%) |
France | 9 (2%) |
United Kingdom of Great Britain and Northern Ireland | 8 (2%) |
India | 6 (1%) |
Singapore | 4 (1%) |
Poland | 4 (1%) |
Mexico | 3 (1%) |
Russian Federation | 3 (1%) |
Netherlands (Kingdom of the) | 3 (1%) |
Portugal | 2 (0%) |
Canada | 2 (0%) |
Italy | 2 (0%) |
South Korea | 2 (0%) |
Saudi Arabia | 1 (0%) |
South Africa | 1 (0%) |
Japan | 1 (0%) |
New Zealand | 1 (0%) |
Denmark | 1 (0%) |
Iran | 1 (0%) |
Taiwan (China) | 1 (0%) |
Bulgaria | 1 (0%) |
Egypt | 1 (0%) |
Philippines | 1 (0%) |
Finland | 1 (0%) |
Unknown (Anonymous Proxy) | 1 (0%) |
Czechia | 1 (0%) |
Croatia | 1 (0%) |
Colombia | 1 (0%) |